Chloramphenicol Gentamycin Sulfate Metoclopramide Neomycin Sulphate Eye Ear Drops

Name: Chloramphenicol Gentamycin Sulfate Metoclopramide Neomycin Sulphate Eye Ear Drops
Brand: Shanghai Himed Pharmaceutical Co., Ltd.
SKU: 1949780915

Shanghai, ChinaShanghai Himed Pharmaceutical Co., Ltd.

US$0.25-0.50

10,000 Pieces

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Application

Surgery

Usage Mode

For external use

Model NO.

5ml 10ml

Suitable for

Adult

State

Liquid

Shape

Liquid

Type

Biological Products

Pharmaceutical Technology

Chemical Synthesis

HS

3004

Dosage

Drops

Usage

Human

Transport

by Sea

Transport Package

Carton

Specification

5ml 10ml 15ml 20ml

Trademark

HIMED or OEM

Origin

China

HS Code

3004909099

Production Capacity

100, 000, 000 Per Year

Key features

Wide Product Range: Offers diverse creams, ointments, and eye/ear drops for various medical needs.

Global Market Reach: Exports to North America, South America, Europe, Asia, Africa, and Oceania.

Flexible Payment Terms: Accepts LC and T/T for secure and convenient international transactions.

Reliable Lead Time: Consistent 1-3 months delivery time for both peak and off-season orders.

Shanghai Export Hub: Convenient shipping via Shanghai port with FOB, EXW, CFR, and CIF terms.

Company profile

Shanghai Himed Pharmaceutical Co., Ltd.

Shanghai, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2016-06-08Nearest Port: shanghaiAverage Response Time: ≤1.78hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, EXW, CFR, CIF

AI-Powered supplier vetting

SummaryShanghai Himed Pharmaceutical Co., Ltd. is identified as both a trading company and manufacturer/factory in China, focused on pharmaceuticals and medical supplies for international markets. It reports ISO 9001 and GMP certifications, more than 10 production lines, 6–10 quality-control staff, and 6–10 years of R&D engineering experience. The company states that it has exported since 2016 and serves markets across Asia, Africa, Europe, the Americas, the Middle East, and Oceania. Its stated export share is 41%–50%, with Shanghai listed as the nearest port and typical fulfillment times of 2–3 months in both off-peak and peak seasons. Evidence supports production, certification, international trading, and some customer-case experience, while after-sales service, financial credibility, innovation performance, and customization capacity remain insufficiently documented.

Supplier typeThe supplier is explicitly classified as both a trading company and manufacturer/factory. Its stated business focuses on finished medicines and medical supplies, with product keywords including syringes, gloves, oxygen concentrators, sutures, bandages, gauze, test kits, and blood collection tubes.

CertificationsThe supplier reports holding ISO 9001 and GMP certifications. These are explicit quality-management and pharmaceutical manufacturing credentials, although the provided information does not include certificate numbers, issuing bodies, validity dates, or scope.

Production capacityThe company identifies itself as a manufacturer/factory, reports more than 10 production lines, and lists 6–10 quality-control staff. It has exported since 2016, reports an export-sales share of 41%–50%, and serves broad international markets; these points support established production and export operations, although actual capacity by product is not provided.

Customization capabilityThe supplier states that it can supply both its own brands and customer brands, which directly supports customer-brand supply capability. The information does not confirm broader customization such as formulation changes, packaging development, private-label regulatory support, or minimum-order flexibility.

Client casesThe company claims exports to many countries across Asia, South America, Africa, the Middle East, and Europe, and one trade record identifies STE PHARMA CAMEROUNAISE GALENICA as an associated buyer with Cameroon listed in the trade data. The evidence demonstrates at least one identifiable buyer case, but the overall customer portfolio and transaction history are limited in the provided slices.